Classical Hodgkin Lymphoma: Clinicopathologic Features, Prognostic Factors, and Outcomes From a 28-Year Single Institutional Experience-Reference-Cited by-同舟云学术

Classical Hodgkin Lymphoma: Clinicopathologic Features, Prognostic Factors, and Outcomes From a 28-Year Single Institutional Experience

Published:2021-02 Issue:2 Volume:21 Page:132-138
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Rose Ashley^ORCID,Grajales-Cruz Ariel,Lim Alex,Todd Amber,Bello Celeste,Shah Bijal,Chavez Julio,Pinilla-Ibartz Javier,Saeed Hayder,Sandoval-Sus Jose,Isenalumhe Leidy,Sokol Lubomir

Funder

Incyte

Jazz

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Part II: Hodgkin’s lymphoma—diagnosis and treatment;Diehl;Lancet Oncol,2004

2. ABVD versus BEACOPP for Hodgkin’s lymphoma when high-dose salvage is planned;Viviani;N Engl J Med,2011

3. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin’s lymphoma: 10 years of follow-up of the GHSG HD9 study;Engert;J Clin Oncol,2009

4. Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma;Radford;N Engl J Med,2015

5. A prognostic score for advanced Hodgkin’s disease;Hasenclever;N Engl J Med,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging and cancer;Molecular Cancer;2024-05-18

2. Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review;Journal of Clinical Medicine;2023-09-22

3. PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies;Cancers;2022-11-30

4. Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China;Journal of Cancer Research and Clinical Oncology;2022-08-28